C12N 2795/18134
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2795/18134 (Use of virus or viral component as vaccine) appears on 9 US grants and 26 published applications in this corpus.
Search patents in C12N- Granted patents
- 9
- Published applications
- 26
- Assignees
- 15
- Inventors
- 40
- Latest grant
- 10 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 2 |
| 2017 | 0 | 1 |
| 2018 | 1 | 2 |
| 2019 | 1 | 2 |
| 2020 | 0 | 1 |
| 2021 | 1 | 2 |
| 2022 | 1 | 1 |
| 2023 | 2 | 0 |
| 2024 | 1 | 4 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions targeting apoptosis-associated speck-like protein with caspase activation and recruitment domain (ASC) and methods of use10 Dec 2024US 12,162,916 B2UNM Rainforest Innovations
- Compositions comprising a PCSK9 peptide conjugated to a qbeta carrier and methods of using the same11 Jul 2023US 11,696,941 B2The USA, as represented by the Secretary, Dept. of Health and Human Services
- Vaccine and therapeutic compositions comprising antigen-conjugated viral capsids14 Feb 2023US 11,576,957 B2Board of Trustees of Michigan State University
- EGFRvIII immunogen and methods for using same20 Dec 2022US 11,530,242 B2
- Composition comprising PCSK9 peptide conjugated to a Qbeta carrier and methods of using the same23 Feb 2021US 10,925,938 B2The USA, as represented by the Secretary, Dept. of Health and Human Services
- Sialokinin immunogen and methods for using same13 Aug 2026US 2026/0234184 A1
- Pathogen-like antigen-based vaccine and preparation method therefor2 Oct 2025US 2025/0302940 A1Institute of Biophysics, Chinese Academy of Sciences
- Compositions targeting apoptosis-associated speck-like protein with caspase activation and recruitment domain (asc) and methods of use6 Feb 2025US 2025/0042962 A1UNM Rainforest Innovations
- Immunotherapy compositions and methods for treatment of tauopathy and transgenic mouse12 Sep 2024US 2024/0299512 A1UNM Rainforest Innovations
- Compositions targeting apoptosis-associated speck-like protein with caspase activation and recruitment domain (asc) and methods of use22 Aug 2024US 2024/0279295 A1UNM Rainforest Innovations
Most cited
By later US patents
- Molecular antigen array25US 7,320,793 B2Cytos Biotechnology AG · 2008
- Molecular antigen array13US 7,264,810 B2Cytos Biotechnology AG · 2007
- PCSK9 peptide vaccine conjugated to a Qbeta carrier and methods of using the same2US 10,279,019 B2Stc. Unm · 2019
- Composition comprising PCSK9 peptide conjugated to a Qbeta carrier and methods of using the same2US 10,925,938 B2The USA, as represented by the Secretary, Dept. of Health and Human Services · 2021